X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
transthyretin (8) 8
liver-transplantation (7) 7
polyneuropathy (7) 7
tafamidis (7) 7
humans (6) 6
neurosciences (6) 6
clinical neurology (5) 5
female (5) 5
hereditary amyloidosis (5) 5
male (5) 5
neurology (5) 5
patisiran (5) 5
clinical trials (4) 4
familial amyloid polyneuropathy (4) 4
hereditary transthyretin-mediated amyloidosis (4) 4
medicine & public health (4) 4
middle aged (4) 4
pharmacology & pharmacy (4) 4
adult (3) 3
aged (3) 3
amyloid (3) 3
amyloid neuropathies, familial - genetics (3) 3
amyloid neuropathies, familial - physiopathology (3) 3
amyloidosis (3) 3
autonomic nervous system (3) 3
diagnosis (3) 3
genetic aspects (3) 3
medical research (3) 3
medicine, experimental (3) 3
medicine, research & experimental (3) 3
mutation (3) 3
neuropathy (3) 3
neurosurgery (3) 3
peripheral neuropathy (3) 3
polyneuropathies (3) 3
proteins (3) 3
psychiatry (3) 3
transplantation (3) 3
amyloid - metabolism (2) 2
amyloid neuropathies, familial - diagnosis (2) 2
antisense oligonucleotide (2) 2
antisense oligonucleotides (2) 2
biopsy (2) 2
carriers (2) 2
clinical-trial (2) 2
disease (2) 2
efficacy (2) 2
gene expression (2) 2
gene silencing (2) 2
health aspects (2) 2
hereditary transthyretin amyloidosis (2) 2
inotersen (2) 2
liver transplantation (2) 2
management (2) 2
medicine (2) 2
neuroradiology (2) 2
original (2) 2
original articles (2) 2
patients (2) 2
pharmaceuticals (2) 2
prealbumin - genetics (2) 2
progression (2) 2
ribonucleic acid interference (2) 2
rna interference (2) 2
safety (2) 2
therapy (2) 2
ttr amyloidosis (2) 2
2'-o-methoxyethyl (1) 1
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (1) 1
abridged index medicus (1) 1
acute intermittent porphyria (1) 1
allografts (1) 1
aluminum compounds (1) 1
aminolevulinic acid (1) 1
amyloid - genetics (1) 1
amyloid neuropathies, familial - blood (1) 1
amyloid neuropathies, familial - diagnostic imaging (1) 1
amyloid neuropathies, familial - drug therapy (1) 1
amyloid neuropathies, familial - metabolism (1) 1
amyloid neuropathies, familial - pathology (1) 1
amyloid neuropathies, familial - therapy (1) 1
amyloid polyneuropathy (1) 1
amyloidogenesis (1) 1
angioedema (1) 1
animal models (1) 1
aspiration (1) 1
autonomic dysfunction in amyloidosis (1) 1
axonal excitability (1) 1
axons (1) 1
baclofen (1) 1
basal lamina (1) 1
basic medicine (1) 1
benzoxazoles - pharmacology (1) 1
biochemistry & molecular biology (1) 1
bioindicators (1) 1
biomarkers (1) 1
biomarkers - blood (1) 1
biotechnology industry (1) 1
blood cells - metabolism (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


EXPERT REVIEW OF CLINICAL PHARMACOLOGY, ISSN 1751-2433, 08/2019, Volume 12, Issue 8, pp. 701 - 711
Introduction: Hereditary transthyretin-mediated amyloidosis (ATTRv; v for variant) is an underdiagnosed, progressive, and fatal multisystemic disease with a... 
STABILIZES HUMAN TRANSTHYRETIN | LIVER-TRANSPLANTATION | MANAGEMENT | EFFICACY | transthyretin | peripheral neuropathy | AMYLOIDOGENESIS | CARRIERS | ribonucleic acid interference | Hereditary transthyretin-mediated amyloidosis | TAFAMIDIS | inotersen | PHARMACOLOGY & PHARMACY | cardiomyopathy | PROGRESSION | MANIFESTATIONS
Journal Article
Pharmaceuticals (Basel, Switzerland), ISSN 1424-8247, 05/2019, Volume 12, Issue 2, p. 78
Tegsedi (Inotersen) is a chemically modified antisense oligonucleotide that inhibits the hepatic production of transthyretin (TTR). Several single-point... 
gene silencing | Tegsedi (Inotersen) | antisense oligonucleotide | hereditary transthyretin-mediated amyloidosis (hATTR) | hATTR treatment | transthyretin
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 02/2019, Volume 12, Issue 2, pp. 95 - 99
Introduction: Hereditary transthyretin-mediated amyloidosis is caused by a mutation in transthyretin (TTR) gene resulting in misfolded TTR protein accumulating... 
infusion-related reactions | patisiran | Hereditary transthyretin-mediated amylodiosis | transthyretin | ribonucleic acid interference | POLYNEUROPATHY | LIVER-TRANSPLANTATION | EFFICACY | SAFETY | THERAPY | TAFAMIDIS | DRUGS | PHARMACOLOGY & PHARMACY
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 03/2019, Volume 20, Issue 4, pp. 473 - 481
Background: Hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) is a progressive, life-threatening disease. Until recently, tafamidis was the... 
indirect treatment comparison | Hereditary transthyretin-mediated amyloidosis | RNA interference | patisiran | tafamidis | TTR-FAP | METAANALYSIS | CLINICAL-TRIAL | TASK-FORCE | SAFETY | CARE DECISION-MAKING | PHARMACOLOGY & PHARMACY | Index Medicus
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 10/2019, Volume 405, pp. 116424 - 116424
Hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) is a rare, life-threatening disease, caused by point mutations in the transthyretin gene. It... 
Hereditary transthyretin-mediated amyloidosis | Neuropathy impairment score | Modified neuropathy impairment score+7 | Polyneuropathy | Index Medicus
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 12/2015, Volume 10, Issue 1, pp. 109 - 109
Journal Article
Brain, ISSN 0006-8950, 2015, Volume 138, Issue 3, pp. 549 - 562
Journal Article
by Hund, E
Der Nervenarzt, ISSN 0028-2804, 10/2014, Volume 85, Issue 10, pp. 1291 - 1297
Hereditäre Amyloidosen sind autosomal-dominant vererbte Multisystemerkrankungen mit fatalem Ausgang, die auf extrazellulären Ablagerungen fehlgefalteter... 
Lebertransplantation | Orale Therapie | Hereditary amyloidosis | Oral therapy | Transthyretin | Psychotherapy | Neurosurgery | Medicine/Public Health, general | Familial amyloid polyneuropathy | Familiäre Amyloidpolyneuropathie | Neurology | Hereditäre Amyloidose | Medicine & Public Health | Psychiatry | Liver transplantation
Journal Article
Pharmacogenomics and Personalized Medicine, ISSN 1178-7066, 11/2017, Volume 10, pp. 267 - 278
Journal Article
神経治療学, ISSN 0916-8443, 2018, Volume 35, Issue 3, pp. 278 - 282
Transthyretin (TTR) is a representative amyloidogenic protein in humans. TTR protein destabilised by TTR gene mutation is prone to dissociate from its native... 
amyloid | disease modifying therapy | familial amyloid polyneuropathy | transthyretin | hereditary ATTR amyloidosis
Journal Article
Journal Article
Clinical Autonomic Research, ISSN 0959-9851, 4/2019, Volume 29, Issue 2, pp. 245 - 251
Journal Article
Neurological Sciences, ISSN 1590-1874, 4/2019, Volume 40, Issue 4, pp. 661 - 669
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.